Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Analysis of data from randomized controlled trials : a practical guide / / Jos W. R. Twisk
| Analysis of data from randomized controlled trials : a practical guide / / Jos W. R. Twisk |
| Autore | Twisk Jos W. R. <1962-> |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (167 pages) |
| Disciplina | 616.027 |
| Soggetto topico |
Clinical trials
Assaigs clínics |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-81865-9 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996466413903316 |
Twisk Jos W. R. <1962->
|
||
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Bayesian adaptive design for immunotherapy and targeted therapy / / by Haitao Pan, Ying Yuan
| Bayesian adaptive design for immunotherapy and targeted therapy / / by Haitao Pan, Ying Yuan |
| Autore | Pan Haitao |
| Edizione | [First edition 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (XI, 262 p. 58 illus., 50 illus. in color.) : illustrations |
| Disciplina | 570.15195 |
| Soggetto topico |
Biometry
Biostatistics Clinical Trial Protocols as Topic Adaptive Clinical Trials as Topic Bayes Theorem Immunoteràpia Dianes farmacològiques Assaigs clínics Estadística matemàtica Estadística bayesiana |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-19-8176-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction to Adaptive Design and Delayed Outcomes -- Basics of Bayesian Statistics -- Phase I Dose-finding Design -- Phase II Design for Interim Monitoring -- Phase I-II Dose-finding Design -- Drug Combination Trial Design -- Conclusion. |
| Record Nr. | UNINA-9910717420903321 |
|
Pan Haitao
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Behavioral clinical trials for chronic diseases : scientific foundations / / Lynda H. Powell, Kenneth E. Freedland, Peter G. Kaufmann
| Behavioral clinical trials for chronic diseases : scientific foundations / / Lynda H. Powell, Kenneth E. Freedland, Peter G. Kaufmann |
| Autore | Powell Lynda H. |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (324 pages) |
| Disciplina | 616.044 |
| Soggetto topico |
Chronic diseases
Behavior therapy - Research Chronic diseases - Treatment - Research Malalties cròniques Teràpia de la conducta Investigació mèdica Assaigs clínics |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-39330-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910502589503321 |
|
Powell Lynda H.
|
||
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fundamentals of clinical trials / / by Lawrence M. Friedman, Curt D. Furberg, David L. DeMets, David M. Reboussin, Christopher B. Granger
| Fundamentals of clinical trials / / by Lawrence M. Friedman, Curt D. Furberg, David L. DeMets, David M. Reboussin, Christopher B. Granger |
| Autore | Friedman Lawrence M |
| Edizione | [5th ed. 2015.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 |
| Descrizione fisica | 1 online resource (XXI, 550 p. 49 illus., 7 illus. in color.) |
| Disciplina | 610.724 |
| Soggetto topico |
Assaigs clínics
Statistics Public health Epidemiology Cancer - Research Oncology Statistics for Life Sciences, Medicine, Health Sciences Public Health Cancer Research |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-319-18539-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction to Clinical Trials -- Ethical Issues -- What is the Question? -- Study Population -- Basic Study Design -- The Randomization Process -- Blinding -- Sample Size -- Baseline Assessment -- Recruitment of Study Participants -- Data Collection and Quality Control -- Assessment and Reporting of Harm -- Assessment of Health Related Quality of Life -- Participant Adherence -- Survival Analysis -- Monitoring Committee Structure & Function -- Statistical Methods Used in Interim Monitoring -- Issues in Data Analysis -- Closeout -- Reporting and Interpreting of Results -- Multicenter Trials -- Regulatory Issues. |
| Record Nr. | UNINA-9910299767003321 |
|
Friedman Lawrence M
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Principles and practice of clinical trials / / edited by Steven Piantadosi and Curtis L. Meinert
| Principles and practice of clinical trials / / edited by Steven Piantadosi and Curtis L. Meinert |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (2573 pages) : illustrations (some color) |
| Disciplina | 610.727 |
| Soggetto topico |
Clinical trials
Statistics Clinical trials - Statistical methods Assaigs clínics |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-319-52636-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- A Foreword to the Principles and Practice of Clinical Trials -- Preface -- Acknowledgments -- Contents -- About the Editors -- About the Section Editors -- Contributors -- Part I: Perspectives on Clinical Trials -- 1 Social and Scientific History of Randomized Controlled Trials -- Introduction -- Early History of Clinical Trials -- Refining Trial Methods in the Early Twentieth Century -- The Role of Governments in the Institutionalization of Randomized Controlled Trials -- Historical Trial Ethics -- RCTs and Evidence-Based Medicine -- The Globalization of RCTs and the Challenges of Similarities and Differences in Global Populations -- Social and Scientific Challenges in Randomized Controlled Trials -- Summary and Conclusion -- Key Facts -- Cross-References -- References -- 2 Evolution of Clinical Trials Science -- Introduction -- The Scientific MethodScience is the study of natural phenomena, which are accessible to both passive and active observation. P... -- Some Key Evolutionary Developments -- Ethics -- Governance ModelsRunning a clinical trial in the modern world is not simple and requires some unique governance features. Whil... -- Computerization -- Statistical Advances -- A Likely Future -- Final Comments -- Key Facts -- Cross-References -- References -- 3 Terminology: Conventions and Recommendations -- Introduction -- Clinical Trial -- Trial Versus Study -- Pilot Study Versus Feasibility Study -- Name of Trial -- Name of the Experimental Variable: Treatment Versus Intervention -- Name for Groups Represented by Experimental Variable: Study Group, Treatment Group, or Arm -- Persons Studied: Subject, Patient, or Participant -- Trial Protocol Versus Manual of Operations -- Blocking Versus Stratification and Quotafication -- Open -- Controlled -- Placebo -- Consent -- Randomization Versus Randomized -- Registration Versus Enrollment.
Single Center Trial Versus Multicenter Trial -- Multicenter Versus Cooperative Versus Collaborative -- Principal Investigator (PI) Versus Study Chair -- Clinical Investigator Versus Investigator -- Steering Committee Versus Executive Committee -- Data Monitoring Versus Data Monitoring Committee -- Random Versus Haphazard -- Primary Versus Secondary Outcomes -- Outcome Versus Endpoint -- Treatment Failure Versus Treatment Cessation -- Blind Versus Mask -- Lost to Followup -- Dropout -- Withdrawals -- Design Variable Versus Primary Outcome Measure -- Baseline Versus Baseline Period -- Screened Versus Enrolled -- End of Followup Versus End of Trial -- Analysis by Assigned Treatment Versus Per Protocol Analysis -- Bias -- Early Stop Versus Nominal Stop -- Summary -- References -- 4 Clinical Trials, Ethics, and Human Protections Policies -- Origins of Research Ethics -- Conception of Trials -- Design of Trials -- Risk/Benefit -- Justification of Therapeutic Procedures: Clinical Equipoise -- Justification of Demarcated Research Procedures -- Riskless Research, High Risk Research, Comparative Effectiveness Trials, and Ethics -- Maximizing Efficiencies -- Justice -- Fair Subject Selection -- Inclusion -- Trial Inception -- Respect for Persons -- Elements of Valid Informed Consent -- Research Without Informed Consent -- Informed Consent Documents -- Independent Review -- Conduct -- Trials and Ethics Across Time -- Reporting -- Publication and Results Deposition -- Methods and Outcome Reporting -- The Afterlife of Trials -- Synthesis -- Cross-References -- References -- 5 History of the Society for Clinical Trials -- Introduction -- Background: 1967-1972 -- Steps in the Creation of the Society for Clinical Trials -- Meetings of Coordinating Center Personnel -- Coordinating Center Models Project -- National Conference on Clinical Trials Methodology. Journals of the Society for Clinical Trials -- International Participation -- Summary and Conclusion -- References -- Part II: Conduct and Management -- 6 Investigator Responsibilities -- Introduction -- Definitions -- Research -- Investigators -- Overall Responsibilities of Investigators -- Research Study Design and Conduct -- Design -- Conduct -- Qualifications, Training, and Delegation of Tasks -- The Clinical Research Team -- Accountability of Investigational Agents -- Data Collection, Research Record Maintenance, and Retention -- Reporting of Research Findings -- Safeguards to Protect Research Participants -- Adverse Event Reporting -- Safety Oversight -- IRB Requirements -- Informed Consent Process -- Protocol Noncompliance and Research Misconduct -- Protocol Noncompliance -- Research Misconduct -- Summary and Conclusion -- Key Facts -- Regulations and Policies -- Cross-References -- References -- 7 Centers Participating in Multicenter Trials -- Introduction -- Roles and Functions of Resource Centers -- Coordinating Centers -- Clinical Coordinating Centers -- Data Coordinating Centers -- Other Resource Centers -- Clinical Centers -- The Implementation Phase -- Organizing the Site -- Assembling the Study Team -- Attributes of the Principal Investigator -- Attributes of the Clinical Coordinator -- Interactions with the Team -- Ethical Approval -- Organization Binders/Files -- Certification and Training -- Participant Enrollment Phase -- Recruitment -- Screening and Randomization -- Treatment and Follow-Up Phase -- Scheduling and Communications -- Adverse Events -- Data Collection -- Data Management -- Site Visits -- Study Meetings -- Participant Closeout Phase -- Final Follow-Up Visit -- Post-Funding Phase -- Dissemination of Study Results -- Summary and Conclusion -- Key Facts -- Cross-References -- References. 8 Qualifications of the Research Staff -- Introduction -- History of Clinical Research Staff -- Staff Qualifications -- Training -- Credentialing Organizations in Clinical Research -- Summary -- Key Facts -- Cross-References -- References -- 9 Multicenter and Network Trials -- Introduction -- Multicenter Clinical Trials -- Formation -- Trial Leadership -- Design Considerations -- Coordination of Study Activities and Logistics Between Sites -- Clinical Trial Networks -- Summary and Conclusions -- Key Facts -- Cross-References -- References -- 10 Principles of Protocol Development -- Introduction -- Administrative Information: SPIRIT Checklist Items 1-5d -- Background and Rationale and Objectives: SPIRIT Checklist Items 6-7 -- Trial Design: SPIRIT Checklist Item 8 -- Participants, Interventions, and Outcomes: SPIRIT Checklist Items 9-17b -- Participants -- Interventions -- Outcomes -- Participant Timeline, Sample Size Recruitment (Items 13-15) -- Sample Size -- Recruitment -- Assignment of Interventions (for Controlled Trials): Spirit Checklist Items 16-17b -- Data Collection/Management and Analysis: SPIRIT Checklist Items 18a-20c -- Data Collection -- Data Management -- Statistical Analysis -- Monitoring: SPIRIT Checklist Items 21-23 -- Data Monitoring -- Efficacy -- Harm -- Quality Assurance (Monitoring/Auditing) -- Ethics and Dissemination: SPIRIT Checklist Items 24-31c -- Ethics -- Dissemination -- Conclusion -- References -- 11 Procurement and Distribution of Study Medicines -- Introduction -- Procurement of Investigational Product -- Investigational Product Procurement Planning -- Use of a Generic Drug -- Considerations for IP Procurement/Manipulation in Blinded Trials -- Impact of IP-Related Factors: Controlled Substances -- Identification of Qualified Vendors -- Packaging Considerations. Manufacturing and Packaging Considerations for Blinded Trials -- International Clinical Trials -- Distribution of Investigational Product -- Documents to Support Release of IP to Qualified Sites -- Use of Controlled Substances in Clinical Trials -- IP Inventory Management for Complex Study Designs -- IP Accountability -- Shipping and Receipt of IP -- Quality Assurance -- Summary and Conclusion -- Key Facts -- References -- 12 Selection of Study Centers and Investigators -- Introduction -- Site and Investigator Selection Plan -- Site Selection -- Facility Resources -- Site and Process Flow -- Administrative Considerations -- Recruitment Potential -- Regulatory and Ethics Requirements -- Investigator Selection -- Investigator Responsibilities -- Investigator Qualification -- Investigative Team Considerations -- Investigator Equipoise -- Investigator Motivation -- Site Team Dynamics -- Research Experience and Past Performance -- Site and Investigator Selection Methods -- Surveys and Questionnaires -- Site Qualification Visit -- Summary -- Key Facts -- References -- 13 Design and Development of the Study Data System -- Introduction -- Descriptive Overview -- System Components: The Naming of Parts -- The Rise of the eRDC Workflow -- Deployment Options and Implications -- Constructing the Study Definition -- Overview -- Working from the Protocol -- Working Up the Functional Specification -- ``User Acceptance Testing´´ -- Final Approval of the Specification -- Using Data Standards -- Validating the Specification and Final Release -- Development and Testing Environments -- The Study Data System in the Longer Term -- Change Management -- Exporting the Data for Analysis -- Summary and Conclusion -- Key Facts -- Cross-References -- References -- 14 Implementing the Trial Protocol -- Introduction -- Protocol Development -- Site Selection, Feasibility, and Set Up. Site Characteristics. |
| Record Nr. | UNINA-9910585772403321 |
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Principles and practice of clinical trials / / edited by Steven Piantadosi and Curtis L. Meinert
| Principles and practice of clinical trials / / edited by Steven Piantadosi and Curtis L. Meinert |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (2573 pages) : illustrations (some color) |
| Disciplina | 610.727 |
| Soggetto topico |
Clinical trials
Statistics Clinical trials - Statistical methods Assaigs clínics |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-319-52636-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- A Foreword to the Principles and Practice of Clinical Trials -- Preface -- Acknowledgments -- Contents -- About the Editors -- About the Section Editors -- Contributors -- Part I: Perspectives on Clinical Trials -- 1 Social and Scientific History of Randomized Controlled Trials -- Introduction -- Early History of Clinical Trials -- Refining Trial Methods in the Early Twentieth Century -- The Role of Governments in the Institutionalization of Randomized Controlled Trials -- Historical Trial Ethics -- RCTs and Evidence-Based Medicine -- The Globalization of RCTs and the Challenges of Similarities and Differences in Global Populations -- Social and Scientific Challenges in Randomized Controlled Trials -- Summary and Conclusion -- Key Facts -- Cross-References -- References -- 2 Evolution of Clinical Trials Science -- Introduction -- The Scientific MethodScience is the study of natural phenomena, which are accessible to both passive and active observation. P... -- Some Key Evolutionary Developments -- Ethics -- Governance ModelsRunning a clinical trial in the modern world is not simple and requires some unique governance features. Whil... -- Computerization -- Statistical Advances -- A Likely Future -- Final Comments -- Key Facts -- Cross-References -- References -- 3 Terminology: Conventions and Recommendations -- Introduction -- Clinical Trial -- Trial Versus Study -- Pilot Study Versus Feasibility Study -- Name of Trial -- Name of the Experimental Variable: Treatment Versus Intervention -- Name for Groups Represented by Experimental Variable: Study Group, Treatment Group, or Arm -- Persons Studied: Subject, Patient, or Participant -- Trial Protocol Versus Manual of Operations -- Blocking Versus Stratification and Quotafication -- Open -- Controlled -- Placebo -- Consent -- Randomization Versus Randomized -- Registration Versus Enrollment.
Single Center Trial Versus Multicenter Trial -- Multicenter Versus Cooperative Versus Collaborative -- Principal Investigator (PI) Versus Study Chair -- Clinical Investigator Versus Investigator -- Steering Committee Versus Executive Committee -- Data Monitoring Versus Data Monitoring Committee -- Random Versus Haphazard -- Primary Versus Secondary Outcomes -- Outcome Versus Endpoint -- Treatment Failure Versus Treatment Cessation -- Blind Versus Mask -- Lost to Followup -- Dropout -- Withdrawals -- Design Variable Versus Primary Outcome Measure -- Baseline Versus Baseline Period -- Screened Versus Enrolled -- End of Followup Versus End of Trial -- Analysis by Assigned Treatment Versus Per Protocol Analysis -- Bias -- Early Stop Versus Nominal Stop -- Summary -- References -- 4 Clinical Trials, Ethics, and Human Protections Policies -- Origins of Research Ethics -- Conception of Trials -- Design of Trials -- Risk/Benefit -- Justification of Therapeutic Procedures: Clinical Equipoise -- Justification of Demarcated Research Procedures -- Riskless Research, High Risk Research, Comparative Effectiveness Trials, and Ethics -- Maximizing Efficiencies -- Justice -- Fair Subject Selection -- Inclusion -- Trial Inception -- Respect for Persons -- Elements of Valid Informed Consent -- Research Without Informed Consent -- Informed Consent Documents -- Independent Review -- Conduct -- Trials and Ethics Across Time -- Reporting -- Publication and Results Deposition -- Methods and Outcome Reporting -- The Afterlife of Trials -- Synthesis -- Cross-References -- References -- 5 History of the Society for Clinical Trials -- Introduction -- Background: 1967-1972 -- Steps in the Creation of the Society for Clinical Trials -- Meetings of Coordinating Center Personnel -- Coordinating Center Models Project -- National Conference on Clinical Trials Methodology. Journals of the Society for Clinical Trials -- International Participation -- Summary and Conclusion -- References -- Part II: Conduct and Management -- 6 Investigator Responsibilities -- Introduction -- Definitions -- Research -- Investigators -- Overall Responsibilities of Investigators -- Research Study Design and Conduct -- Design -- Conduct -- Qualifications, Training, and Delegation of Tasks -- The Clinical Research Team -- Accountability of Investigational Agents -- Data Collection, Research Record Maintenance, and Retention -- Reporting of Research Findings -- Safeguards to Protect Research Participants -- Adverse Event Reporting -- Safety Oversight -- IRB Requirements -- Informed Consent Process -- Protocol Noncompliance and Research Misconduct -- Protocol Noncompliance -- Research Misconduct -- Summary and Conclusion -- Key Facts -- Regulations and Policies -- Cross-References -- References -- 7 Centers Participating in Multicenter Trials -- Introduction -- Roles and Functions of Resource Centers -- Coordinating Centers -- Clinical Coordinating Centers -- Data Coordinating Centers -- Other Resource Centers -- Clinical Centers -- The Implementation Phase -- Organizing the Site -- Assembling the Study Team -- Attributes of the Principal Investigator -- Attributes of the Clinical Coordinator -- Interactions with the Team -- Ethical Approval -- Organization Binders/Files -- Certification and Training -- Participant Enrollment Phase -- Recruitment -- Screening and Randomization -- Treatment and Follow-Up Phase -- Scheduling and Communications -- Adverse Events -- Data Collection -- Data Management -- Site Visits -- Study Meetings -- Participant Closeout Phase -- Final Follow-Up Visit -- Post-Funding Phase -- Dissemination of Study Results -- Summary and Conclusion -- Key Facts -- Cross-References -- References. 8 Qualifications of the Research Staff -- Introduction -- History of Clinical Research Staff -- Staff Qualifications -- Training -- Credentialing Organizations in Clinical Research -- Summary -- Key Facts -- Cross-References -- References -- 9 Multicenter and Network Trials -- Introduction -- Multicenter Clinical Trials -- Formation -- Trial Leadership -- Design Considerations -- Coordination of Study Activities and Logistics Between Sites -- Clinical Trial Networks -- Summary and Conclusions -- Key Facts -- Cross-References -- References -- 10 Principles of Protocol Development -- Introduction -- Administrative Information: SPIRIT Checklist Items 1-5d -- Background and Rationale and Objectives: SPIRIT Checklist Items 6-7 -- Trial Design: SPIRIT Checklist Item 8 -- Participants, Interventions, and Outcomes: SPIRIT Checklist Items 9-17b -- Participants -- Interventions -- Outcomes -- Participant Timeline, Sample Size Recruitment (Items 13-15) -- Sample Size -- Recruitment -- Assignment of Interventions (for Controlled Trials): Spirit Checklist Items 16-17b -- Data Collection/Management and Analysis: SPIRIT Checklist Items 18a-20c -- Data Collection -- Data Management -- Statistical Analysis -- Monitoring: SPIRIT Checklist Items 21-23 -- Data Monitoring -- Efficacy -- Harm -- Quality Assurance (Monitoring/Auditing) -- Ethics and Dissemination: SPIRIT Checklist Items 24-31c -- Ethics -- Dissemination -- Conclusion -- References -- 11 Procurement and Distribution of Study Medicines -- Introduction -- Procurement of Investigational Product -- Investigational Product Procurement Planning -- Use of a Generic Drug -- Considerations for IP Procurement/Manipulation in Blinded Trials -- Impact of IP-Related Factors: Controlled Substances -- Identification of Qualified Vendors -- Packaging Considerations. Manufacturing and Packaging Considerations for Blinded Trials -- International Clinical Trials -- Distribution of Investigational Product -- Documents to Support Release of IP to Qualified Sites -- Use of Controlled Substances in Clinical Trials -- IP Inventory Management for Complex Study Designs -- IP Accountability -- Shipping and Receipt of IP -- Quality Assurance -- Summary and Conclusion -- Key Facts -- References -- 12 Selection of Study Centers and Investigators -- Introduction -- Site and Investigator Selection Plan -- Site Selection -- Facility Resources -- Site and Process Flow -- Administrative Considerations -- Recruitment Potential -- Regulatory and Ethics Requirements -- Investigator Selection -- Investigator Responsibilities -- Investigator Qualification -- Investigative Team Considerations -- Investigator Equipoise -- Investigator Motivation -- Site Team Dynamics -- Research Experience and Past Performance -- Site and Investigator Selection Methods -- Surveys and Questionnaires -- Site Qualification Visit -- Summary -- Key Facts -- References -- 13 Design and Development of the Study Data System -- Introduction -- Descriptive Overview -- System Components: The Naming of Parts -- The Rise of the eRDC Workflow -- Deployment Options and Implications -- Constructing the Study Definition -- Overview -- Working from the Protocol -- Working Up the Functional Specification -- ``User Acceptance Testing´´ -- Final Approval of the Specification -- Using Data Standards -- Validating the Specification and Final Release -- Development and Testing Environments -- The Study Data System in the Longer Term -- Change Management -- Exporting the Data for Analysis -- Summary and Conclusion -- Key Facts -- Cross-References -- References -- 14 Implementing the Trial Protocol -- Introduction -- Protocol Development -- Site Selection, Feasibility, and Set Up. Site Characteristics. |
| Record Nr. | UNISA-996483154503316 |
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
